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Abstract Kawasaki disease (KD) is an acute systemic
vasculitis that is currently the leading cause of acquired
heart disease in childhood in the United States. Cardiovas-
cular complications are the major cause of morbidity, are
responsible for virtually all deaths from KD and should be
evaluated as soon as possible after the acute phase to
establish the baseline status, in order to predict disease
progression and determine adequate treatment. In selected
patients, electrocardiography (ECG)-gated cardiac comput-
ed tomography (CT) and magnetic resonance (MR)
imaging are valuable non-invasive techniques that can be
used to help diagnose the cardiovascular complications
associated with KD. In this article, we review the
epidemiology, aetiology and pathogenesis, histopathology,
clinical features, cardiovascular complications and imaging,
focusing on the role of cardiac CT and MR on the initial
assessment and follow-up of the cardiovascular complica-
tions of KD.
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Introduction
Kawasaki disease (KD) is a self-limiting acute vasculitis
that was first described in 1967 by Dr Tomisaku Kawasaki,
a Japanese paediatrician. Although more than 40 years have
passed since the original description of the clinical signs of
this disease, the diagnosis remains challenging and the
aetiology unclear.
This illness predominantly affects infants and young
children of all ethnic backgrounds and is more frequent
during winter and spring [1–3]. Nevertheless, it is clearly
more prevalent in the Asian population [4]. In Japan, an
annual incidence of 112 up to 175 cases per 100,000
children <5 years old has been reported, whereas in the
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DOI 10.1007/s13244-010-0035-6United States an annual incidence of 20–25 cases per
100,000 children <5 years old has been estimated [1–5].
There is a slightly increased prevalence in boys, with a
male-to-female ratio of 1.3-1.7:1 and 76–80% of the
children are <5 years old [2, 3].
A genetic predisposition has been suggested by higher
rates of KD in the siblings as well as in the children of
parents with a history of KD in childhood [1–5]. A recent
study suggests that polymorphism in some alleles of B and
C in HLA class I are associated with KD in Korean children
[6].
Cardiovascular sequelae are the leading cause of
morbidity and are responsible for virtually all deaths as a
result of coronary vasculitis associated with a hypercoag-
ulable state, leading to myocardial infarct and sudden death
[1–3, 5]. However, with proper treatment, the mortality rate
is less than 1% in either Japan or the United States, with the
peak mortality occurring between the 15th and 45th days
[2, 4].
Aetiology and pathogenesis
The aetiology of KD remains unknown, although the
clinical presentation—self-limiting illness manifested by
an abrupt onset of fever, rash, exanthema, conjunctival
injection and cervical adenopathy—and the epidemiolog-
ical features—a seasonal peak in winter and spring, age
distribution and a geographic wave-like spread of illness
during epidemics—strongly suggest an infectious cause
[1–4]. Nevertheless, after four decades of searching for a
causal agent the researchers have failed to yield an
infectious cause and have only reported a long list of
pathogens that they have ruled out.
The hypothesis of a superantigen leading to up-
regulation of the immune response has been supported by
some studies and refuted by others [1, 2, 4]. In a recent
study, Leung et al. [7] failed to demonstrate a significant
difference in the prevalence of toxin-producing strains
between patients with KD and febrile controls.
An alternative hypothesis suggests the involvement of an
oligoclonal antibody response for a conventional antigen,
with the immunoglobulin A plasma cells playing a vital
role [4].
Nevertheless, significant progress in finding the aetiol-
ogy of KD is still expected in the near future.
Histopathology
KD is a systemic vasculitis that is more severe in small and
medium arteries, and veins to a lesser extent, with
inflammatory lesions in virtually all organs [3, 8]. The
earlier inflammatory changes are observed in the endothe-
lium [1, 2, 4]. More advanced inflammatory lesions are
consistent with oedema and inflammatory cell infiltrate in
the subendothelial space, characterised by an influx of
neutrophils in the first 10 days after onset with a rapid
transition to mononuclear cells with lymphocytes (predom-
inantly CD8
+ T cells) [1–3, 5]. In more severely affected
vessels, the inflammatory lesions tend to progress leading
to necrosis of smooth muscle cell media [2, 5]. Destruction
of internal and external elastic laminae may be seen in
severely affected vessels. Loss of integrity of the wall
vessel results from these changes, which may lead to the
formation of aneurysms [1, 2, 5].
Myocarditis, pericarditis and endocarditis with valvulitis
may also be present in the acute phase [1, 3, 5].
After several weeks to months, the inflammatory
changes of active vasculitis disappear and fibrous connec-
tive tissue, consisting of collagen and elastic fibres, begins
to form within the vessel wall. The lesions in the coronary
arteries continue to develop through an active process of
remodelling characterised by myointimal proliferation and
neoangiogenesis [1–5]. Over time the vessel may become
stenotic or occluded, as a result of either progressive
stenosis or superimposed thrombosis [5].
Principal clinical features and diagnosis criteria
The diagnosis of KD remains challenging, mainly
because of the lack of a specific diagnostic test or
clinical features. The diagnosis is based on the recogni-
tion of the classic clinical features of the illness, which
include fever plus four of five other principal criteria
(Table 1)[ 1, 2, 8].
Fever is usually the first sign of KD and is classically
high (>39°C) and remittent [1–4]. With proper treatment,
the fever usually resolves within 2-3 days, but without it
may persist for several weeks, with an average of 11 days
[1]. Typically, the other clinical signs appear over a period
of several days (>5 days).
Erythema and oedema of hands and feet confined to the
palms and soles usually occurs in the acute phase, with the
desquamation beginning in the periungual region within 10-
20 days [1–3]. Deep transverse grooves across the nails
(Beau’s lines) may appear 1–2 months later [1, 2].
The erythematous rash of KD may take various forms
and is often non-specific [1–3]. Most common is a diffuse
maculopappular erythematous rash (Fig. 1)[ 2]. The rash
usually involves the trunk and extremities with predilection
for the perineum [1, 2].
Bilateral conjunctival injection in KD is distinctive,
usually involving the bulbar conjunctivae and is rarely
exudative or painful [1–4].
224 Insights Imaging (2010) 1:223–231Changes in the lips and oral cavity include erythema,
fissuring, peeling, cracking and bleeding of the lips,
strawberry tongue and diffuse injection of oral and
pharyngeal mucosae without associated mucosal ulcerations
or pharyngeal exudates (Fig.1)[ 1–3].
Cervical lymphadenopathy is the least common of the
main clinical features and is present in only 50–70% of the
cases compared with other principal clinical features that are
present in 90% of cases [2, 3]. It is usually unilateral, non-
suppurative and limited to the anterior cervical triangle [2].
Recurrent episodes, defined as a new onset of illness
after 3 months, can occur in 1% of the children [3].
Some patients with KD do not fulfil all the classic
criteria for the clinical diagnosis. Children with fever and
fewer than four of the other features of the illness present
the so-called atypical or incomplete KD [9]. The atypical
KD is also more common in young children and, as the
recognition of this variant can be quite difficult, they are at
greatest risk of developing coronary artery aneurysms
(CAA) and fatal outcomes have occurred [2, 9]. The
diagnosis in these cases has usually been made through
detection of CAA by echocardiography [2].
KD should be considered in the differential diagnosis of
children with high fever of unexplained cause lasting more
than 5 days with any of the principal clinical features of this
disease, so that the proper treatment can be provided
reducing the frequency and severity of cardiac complica-
tions. Nevertheless, as the diagnostic criteria are not
specific to KD, other diseases with similar clinical features
should be excluded.
Fig. 1 A 3-year-old child with
KD. Photographs show erythema,
fissuring and bleeding of the lips
(a) and diffuse maculopappular
erythematous rash predominating
the trunk and neck, with evident
skin desquamation (b, c, d)
Table 1 Diagnostic criteria for KD
a
Criteria
Fever persisting at least 5 days and the presence of at least four of the following five principal clinical features:
1. Changes in extremities:
Acute: erythema and oedema of hands and feet
Subacute: membranous desquamation of fingertips and periungual peeling
2. Polymorphous exanthema
3. Bilateral, painless bulbar conjunctival injection without exudate
4. Changes in lips and oral cavity: erythema and cracking of lips, strawberry tongue, diffuse injection of oral and pharyngeal mucosae
5. Cervical lymphadenopathy (>1.5 cm in diameter), usually unilateral
aPatients with fever at least 5 days and less than four principal symptoms can be diagnosed as having Kawasaki disease when coronary artery disease is
detected. Other diseases with similar clinical features should be excluded
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A series of other features are typical of KD, although they
are not included in the diagnostic criteria.
In the acute phase, the principal clinical features are
typically accompanied by leukocytosis with neutrophil
predominance and by elevated sedimentation rate and
elevations in the levels of other acute-phase reactants [1–4].
Normocytic anaemia is also common in the acute phase [2].
A low platelet count at presentation has been associated
with the development of severe coronary disease and
myocardial infarction [10]. In later phases, usually after
the second week, thrombocytosis is a characteristic finding
[2, 3].
Mild to moderate elevations in serum transaminases and
hypoalbuminaemia are also common findings [3].
Changes in chest radiographs are frequent. Umezawa et al.
[11] found that 14.7% of children with KD had abnormal
findings, including reticulogranular pattern in 89.5%, peri-
bronchial cuffing in 21.1%, pleural effusion in 15.8%,
atelectasis in 10.5% and air trapping in 5.3%.
At ultrasound examination, gallbladder hydrops (5%),
which is generally self-limiting, and enlarged kidneys with
increased renal echoes and enhanced cortico-medullary
differentiation may be seen [3].
Cardiovascular complications and imaging
KD is the leading cause of acquired heart disease in
childhood in the United States. Cardiovascular complica-
tions are a major cause of morbidity (Table 2), the primary
concern being CAA, which can develop in 15–25% of
untreated children, usually in the subacute phase [1–5].
CAA are classified as small (<5 mm in internal diameter),
medium (5–8 mm) or giant (>8 mm) [1]. CAA are
classified as sacullar or fusiform (Fig. 2), are more
frequently found in the proximal segments and at bifurca-
tions and are often multiple (Fig. 3)[ 12]. The lesions in the
coronary arteries seem to progress differently: the aneur-
ysms in the right coronary artery (RCA) are more prone to
massive thrombosis, whereas those in the left coronary
artery (LCA) are more prone to progressive focal stenosis
[13].
Angiographic spontaneous resolution may occur in about
50% of CAA, especially in the small coronary aneurysms,
although the structural damage in the vessel wall persists
[3, 14, 15]. The size of the aneurysm is a factor in
prognosis, with giant aneurysms (>8 mm) being associated
with a higher risk of rupture, thrombosis and stenosis,
which can cause myocardial infarct and death [2, 13]. Giant
aneurysms usually do not regress (Fig. 4)[ 16].
Several scoring systems have been developed in order
to identify the risk factors for CAA, particularly giant
CAA [17, 18]. Duration of fever has been consistently
reported as a powerful risk factor [1, 17, 18]. Younger
patient age, particularly less than 1 year of age, male sex
and delayed diagnosis and treatment have also been
associated with development of CAA [1, 17, 18].
Laboratory-detected conditions, including leukocytosis,
thrombocytopaenia, lower haemoglobin or haematocrit
and lower serum albumin, are also prominent risk factors
[7, 17, 18].
Treatment with a high dose of intravenous gamma
globulin combined with aspirin has been proved to be
Table 2 Cardiovascular manifestations of KD
Manifestations (in order of frequency):
Coronary artery aneurysms
Myocarditis
Pericarditis with pericardial effusion
Systemic arterial aneurysms
Valvular disease
Mild aortic root dilatation
Myocardial infarct
Fig. 2 A 5-year-old boy with
KD. Reconstructed volume-
rendered 3D CT coronary angi-
ography (a, b) showing a fusi-
form aneurysm (arrow)
involving the middle segment of
the right coronary artery (RCA)
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well the prevalence of CAA to less than 5%, although its
mechanism of action remains unknown [19]. However,
about 10% of patients do not respond favourably to this
treatment, which represents an important clinical dilemma
because of the increased risk of developing CAA [13].
The contribution of KD in childhood to the development
of coronary artery disease in the long term is still
controversial and remains a source of concern. Recent
studies have shown that changes in lipid profile and
endothelial dysfunction persist for a long time after the
resolution of the illness [10, 20]. Noto et al. [21] recently
demonstrated that patients with a history of KD have long-
term structural and functional alterations that increase the
propensity towards subclinical atherosclerosis with age.
The current recommendation of the American Heart
Fig. 3 A 5-year-old boy with KD. Reconstructed volume-rendered
3D CT coronary angiography (a, b, c) revealing coronary arteries
dilatations involving the right coronary artery (RCA), including the
posterior descending artery (PD), the left main (LM)a n dt h e
proximal segments of the left anterior descending artery (LAD)a n d
circumflex artery (Cx) and the ramus intermedium (RI). Maximum-
intensity projection 2D curved planar reformatting CT angiography
of the RCA (d) showing diffuse ectasia (arrow) affecting all
segments, including the PD. Maximum-intensity projection 2D
curved planar reformatting CT angiography of the left coronary
artery (e, f, g) revealing a giant coronary without intraluminal
thrombus of the LM and proximal segments of the LAD, Cx and RI
(arrows)
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[2].
Myocarditis is the most common non-coronary complica-
tion and is present in 50–70% of patients in the acute phase
[1, 2]. Pericarditis with pericardial effusion also frequently
occurs in about 25% of patients in the acute phase [22].
Valvular disease, especially mitral regurgitation, may result
from papillary muscle dysfunction or secondary to rupture of
the chordae tendineae [3], myocardial infarct or valvulitis,
and has been reported in about 1% of patients [22, 23]. Mild
aortic root dilatation is also common in the acute phase and
may be associated with aortic regurgitation [24].
The systemic arterial aneurysms occur in approximately
2% of patients with KD, usually those who also have CAA
[2]. The arteries most affected are the axillary, common
iliac, internal iliac and subclavian (Fig. 5)[ 23]. The
peripheral aneurysms also have a tendency to regress,
similar to CAA. However, rarely serious complications may
occur, such as severe peripheral ischaemia with resultant
gangrene [2, 23].
Cardiac imaging is a critical part of the evaluation of all
patients with KD disease as the major sequelae are related
to CAA. The coronary anomalies should be evaluated as
soon as possible after the acute phase to establish the initial
Fig. 4 A 40-year-old woman
with a history of KD. Recon-
structed volume-rendered 3D
CT coronary angiography (a)
demonstrating the left coronary
artery with a giant fusiform
aneurysm (arrow). Two-
dimensional curved planar
reformatting CTangiography (b)
showing a giant fusiform aneu-
rysm (arrow) 9 mm in diameter
in the left main (LM) coronary
artery and minimal mural calci-
fications (open arrows). MR
coronary angiogram (c, d) and
conventional coronary angio-
gram (e) showing the LM giant
aneurysm (arrow). LAD left
anterior descending, Cx left
circumflex, RCA right coronary
artery
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progression and determine adequate treatment. Evaluation
of the coronary arteries should include quantitative assess-
ment of the internal vessel diameters, as well as the number
and location of the aneurysms, and absence or presence of
intraluminal thrombus [1].
Echocardiography remains the technique of choice for
the assessment of the coronary abnormalities because it
is non-invasive, widely available and has high sensitivity
and specificity for the detection of proximal abnormali-
ties in the coronary tree [1, 2]. However, the visualisation
of coronary arteries cannot always be performed by
echocardiography owing to technical limitations, such as
limited field of vision or inadequate acoustic window,
because as a child grows and the body size increases it
becomes progressively more difficult or there are intrinsic
limitations (inability to delineate the distal coronary
segments or low sensitivity in demonstrating intraluminal
thrombus). In these cases, other techniques—including
angiography, computed tomography (CT) and magnetic
resonance (MR)—may be of value for the assessment of
coronary abnormalities.
Table 3 Comparison of coronary CT angiography and MR imaging in the diagnosis of KD
Technique Advantages Disadvantages When to use
Coronary CT
angiography
Fast Uses ionising radiation Initial diagnostic work-up in patients
with inadequate acoustic window Wide availability
Excellent spatial resolution
High sensitivity and specificity for
detection of coronary abnormalities,
including distal segments
MR imaging No ionising radiation Relatively long examination
times
Follow-up in patients with known CAA
and with inadequate acoustic window
Excellent temporal resolution Low spatial resolution Potential role as complementary examination
in the assessment of cardiovascular
non-coronary complications
Fig. 5 A 16-year-old male patient with a history of KD. Recon-
structed maximum-intensity-projection 3D MR angiography (a)
demonstrating bilateral fusiform aneurysms in the brachial arteries
(arrows). MR coronary angiograms (b, c, d, e) with the maximum-
intensity-projection technique showing normal coronaries, without
evidence of aneurysms
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“gold standard” for the assessment of coronary abnormal-
ities, its invasiveness, high cost, the need for hospitalisation
and potential complications (haematomas, dissections,
vascular rupture, arrhythmias and death) [25]—especially
because most patients with KD are children—should be
weighed against the expected benefits.
In selected patients, CT and MR are attractive non-
invasive alternatives for the initial evaluation of coronary
abnormalities, as well as for the surveillance of coronary
abnormalities, as both are efficient at detecting CAA.
Several recent studies have demonstrated the feasibility
of coronary CT angiography for the assessment of coronary
artery disease with high diagnostic accuracy: high negative
predictive values ranging from 95 to 100% [26–30].
Coronary CT angiography with ECG-gating is fast, widely
available and offers excellent spatial resolution, allowing
the assessment of virtually all coronary segments, including
the distal segments, thus providing an accurate character-
isation or a confident exclusion of CAA, as well as of the
presence of an intraluminal thrombus (Fig. 4).
However,asthisillness affectsmainlychildren,the doseof
radiation remains a major concern. Nevertheless, several
strategies to reduce radiation exposure have been developed,
including tube modulation, the use of lower tube voltages and
of prospective electrocardiographic (ECG) triggering, allow-
ing the reduction of effective radiation dose to the range of
1.3-4.2 mSv [31–34]. Recent studies have demonstrated that
the use of prospective ECG-triggered high-pitch spiral
acquisition using dual-source CT can reduce even more the
effective radiation dose to less than 1 mSv [35–37].
Magneticcoronaryangiographyisadesirablenon-invasive
technique not only because of the lack of ionising radiation
but also because it allows the simultaneous assessment of
coronary and non-coronary abnormalities. Several studies
have reported a 100% agreement for the diagnosis of CAA
between MR coronary angiography and selective coronary
angiography in patients with KD, with excellent agreement
for diameter and length measurements [38–40]. Takemura
et al. [41] demonstrated the utility and feasibility of coronary
MR angiography for the evaluation of CAA, including in the
demonstration of intraluminal thrombus, even in small
children. MR is already accepted as the “gold standard” for
the assessment of LV systolic function, which also allows the
assessment of associated non-coronary cardiovascular com-
plications, such as myocarditis or myocardial infarct. MR
may play a potential role in the acute phase when
myocarditis is suspected. MR imaging findings that are
suggestive of myocarditis include abnormal signal intensity
on STIR-weighted sequences in the affected regions, visible
as an area of hyperintensity and regions of delayed contrast
enhancement affecting the subepicardial myocardium in a
patchy distribution, frequently sparing the subendocardium
and without correlation with a vascular territory, allowing the
differentiation from myocardial infarct [42, 43]. A similar
pattern of enhancement may also be present in the
pericardium when it is also involved in the inflammatory
process [42]. Delayed gadolinium enhancement may be
useful to help determine myocardial viability. MR may also
be used to evaluate peripheral artery aneurysms. The
advantages and disadvantages of coronary CT angiography
and MR imaging are summarised in Table 3.
Conclusion
As cardiovascular sequelae are a major factor in morbidity
and mortality cardiovascular imaging plays a vital role in
the evaluation of all patients with KD. Although echocar-
diography remains the primary imaging technique in the
evaluation of cardiovascular complications, especially in
the acute phase, in selected patients cardiac CT and MR
allow a non-invasive and reliable assessment of cardiovas-
cular complications, as well as at follow-up, especially after
childhood. Invasive coronary angiography should be
reserved for patients with more complex coronary lesions
or for therapeutic measures.
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